-
Meridian Bioscience, Inc. Comments on Preliminary Fiscal 2016 Operating Results and Provides Fiscal 2017 Revenue and Earnings Guidance
18 Oct 2016 20:30 GMT
… 18, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today … upper respiratory infections; serology, parasitology and fungal disease diagnosis, and … Kraeutler
Chairman, Chief Executive Officer
Meridian Bioscience, Inc.
Phone: 513.271. …
-
Meridian Bioscience Expands Its Portfolio and Launches First Analyte Specific Reagent (ASR) Products
23 Aug 2016 13:00 GMT
… 23, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced … upper respiratory infections; serology, parasitology and fungal disease diagnosis, and … Eberly
President, Chief Commercial Officer
Meridian Bioscience, Inc.
Phone: 513.271. …
-
Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance
28 Jul 2016 12:00 GMT
… 28, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported … and upper respiratory infections; serology, parasitology and fungal disease diagnosis, and …
-
Meridian Bioscience Reports Second Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance
28 Apr 2016 11:45 GMT
… 28, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., (NASDAQ:VIVO) today: reported … and upper respiratory infections; serology, parasitology and fungal disease diagnosis, and …
-
Meridian Bioscience Launches New Molecular Test for the Detection of Mycoplasma pneumoniae
27 Apr 2016 11:00 GMT
… 27, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today … implementation of control measures. About Meridian Bioscience, Inc
Meridian is a fully … and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In …
-
Meridian Bioscience Acquires Magellan Diagnostics, Inc.
24 Mar 2016 20:15 GMT
… 24, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ … , “By joining forces with Meridian Bioscience, Magellan Diagnostics will better achieve … upper respiratory infections, serology, parasitology and fungal disease diagnosis. In …
-
Meridian Bioscience Reports First Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance
27 Jan 2016 12:30 GMT
… 27, 2016 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO … earlier, the strength of Meridian Bioscience is in its diversified portfolio … and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In …
-
Faecal Extraction Systems Market Size, Share, Revenue, Trends And Drivers For 2024-2033
10 Oct 2024 01:23 GMT
… Pvt. Ltd., Biohit Healthcare Ltd., Meridian Bioscience Inc., Quidel Corporation, DiaSorin SpA … to identify pathogens, microbes, or parasite particles that could be present …
-
Gastrointestinal Pathogen Testing Market Size to be Worth USD 5.2 billion by 2031, with Notable CAGR of 3.2%| Transparency Market Research, Inc.
02 Jan 2024 14:00 GMT
… , Inc.
Thermo Fisher Scientific, Inc.
Meridian Bioscience, Inc.
Cepheid (Danaher Corporation)
Laboratory … Tests
Culture
Others
Ova and Parasite Microscopy
Molecular Tests
Others
By …
-
Stool Testing Market to grow by USD 445.95 million from 2023 to 2028; North America to account for 40% of market growth- Technavio
12 Dec 2023 03:08 GMT
… Corp., Hologic Inc., McKesson Corp., Meridian Bioscience Inc., Pinnacle BioLabs, Polymedco CDP … extraction of viruses, bacteria, and parasites.
• To gain access to more …
About
© 1995-2025